Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma

The nonnegligible reason for the poor prognosis of hepatocellular carcinoma (HCC) is resistance to conventional chemotherapy. Immunogenic cell death (ICD) is a rare immunostimulatory form of cell death that can reengage the tumor-specific immune system. ICD can improve the clinical outcomes of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhongren, Xu, Jianqiang, Sun, Shibo, Lin, Wei, Li, Yongming, Lu, Qiuyue, Li, Fuwei, Yang, Zhibin, Lu, Yunlong, Liu, Wukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168183/
https://www.ncbi.nlm.nih.gov/pubmed/35671636
http://dx.doi.org/10.1016/j.redox.2022.102351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168183/
https://www.ncbi.nlm.nih.gov/pubmed/35671636
http://dx.doi.org/10.1016/j.redox.2022.102351

Ejemplares similares